Clinical implications of theSETBP1mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical implications of theSETBP1mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 89, Issue 2, Pages 181-186
Publisher
Wiley
Online
2013-10-14
DOI
10.1002/ajh.23611
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
- (2013) F Damm et al. LEUKEMIA
- SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML
- (2013) R R Laborde et al. LEUKEMIA
- The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
- (2012) S.-J. Wu et al. BLOOD
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
- (2012) Rocco Piazza et al. NATURE GENETICS
- DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications
- (2011) H.-A. Hou et al. BLOOD
- TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
- (2011) W.-C. Chou et al. BLOOD
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
- WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system
- (2010) H.-A. Hou et al. BLOOD
- Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation
- (2010) W. C. Chou et al. BLOOD
- Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations
- (2010) W.-C. Chou et al. BLOOD
- The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
- (2010) W-C Chou et al. LEUKEMIA
- De novo mutations of SETBP1 cause Schinzel-Giedion syndrome
- (2010) Alexander Hoischen et al. NATURE GENETICS
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- (2010) Thomas Ernst et al. NATURE GENETICS
- SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia
- (2009) I. Cristobal et al. BLOOD
- AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations
- (2009) J.-L. Tang et al. BLOOD
- Myelodysplastic Syndromes
- (2009) Ayalew Tefferi et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started